Patents by Inventor Xiaobing XIA

Xiaobing XIA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240074807
    Abstract: Disclosed are a microneedle therapy control method and a microneedle therapy control device, and a radio-frequency (RF) microneedle therapy instrument. The microneedle therapy control method comprises the following steps: acquiring a piercing depth of a microneedle electrode; determining, according to the piercing depth of the microneedle electrode, a movement interval of the microneedle electrode in a length direction; sending a first control signal to a linear driver, so as to enable the linear driver to drive the microneedle electrode to move at a preset speed along the length direction within the movement interval; and sending a second control signal to a power module, so as to enable the power module to provide RF energy to the microneedle electrode during the movement of the microneedle electrode in the movement interval.
    Type: Application
    Filed: November 9, 2023
    Publication date: March 7, 2024
    Applicant: SHENZHEN PENINSULA MEDICAL GROUP
    Inventors: Xiaobing LEI, Yanan LI, Yongsheng LIANG, Zhikuan XIA
  • Patent number: 11833220
    Abstract: Provided are an artificial multi-antigen fusion protein and a preparation method thereof. The fusion protein can effectively stimulate CD8+T and CD4+ T cell immunities, and can be applied to immunodiagnostics or serve as a prophylactic or therapeutic vaccine.
    Type: Grant
    Filed: December 15, 2015
    Date of Patent: December 5, 2023
    Assignees: Oxford Vacmedix UK Ltd.
    Inventors: Shisong Jiang, Xiaobing Xia, Hanghai Ding
  • Publication number: 20170340751
    Abstract: Provided are an artificial multi-antigen fusion protein and a preparation method thereof. The fusion protein can effectively stimulate CD8+T and CD4+ T cell immunities, and can be applied to immunodiagnostics or serve as a prophylactic or therapeutic vaccine.
    Type: Application
    Filed: December 15, 2015
    Publication date: November 30, 2017
    Applicants: OXFORD VACMEDIX UK LTD.
    Inventors: Shisong JIANG, Xiaobing XIA, Hanghai DING